Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Plasma CD93 concentration is a potential novel biomarker for coronary artery disease.

Mälarstig A, Silveira A, Wågsäter D, Öhrvik J, Bäcklund A, Samnegård A, Khademi M, Hellenius ML, Leander K, Olsson T, Uhlén M, de Faire U, Eriksson P, Hamsten A.

J Intern Med. 2011 Sep;270(3):229-36. doi: 10.1111/j.1365-2796.2011.02364.x. Epub 2011 Mar 21.

2.

An association study of thrombospondin 1 and 2 SNPs with coronary artery disease and myocardial infarction among South Indians.

Ashokkumar M, Anbarasan C, Saibabu R, Kuram S, Raman SC, Cherian KM.

Thromb Res. 2011 Oct;128(4):e49-53. doi: 10.1016/j.thromres.2011.05.026. Epub 2011 Jul 16.

PMID:
21762961
3.

Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events.

Healy AM, Pickard MD, Pradhan AD, Wang Y, Chen Z, Croce K, Sakuma M, Shi C, Zago AC, Garasic J, Damokosh AI, Dowie TL, Poisson L, Lillie J, Libby P, Ridker PM, Simon DI.

Circulation. 2006 May 16;113(19):2278-84. Epub 2006 May 8.

4.

CD93 gene polymorphism is associated with disseminated colorectal cancer.

Olsen RS, Lindh M, Vorkapic E, Andersson RE, Zar N, Löfgren S, Dimberg J, Matussek A, Wågsäter D.

Int J Colorectal Dis. 2015 Jul;30(7):883-90. doi: 10.1007/s00384-015-2247-1. Epub 2015 May 26.

5.

Polymorphisms in dipeptidyl peptidase IV gene are associated with the risk of myocardial infarction in patients with atherosclerosis.

Aghili N, Devaney JM, Alderman LO, Zukowska Z, Epstein SE, Burnett MS.

Neuropeptides. 2012 Dec;46(6):367-71. doi: 10.1016/j.npep.2012.10.001. Epub 2012 Oct 31.

PMID:
23122333
6.

Epistatic interaction between haplotypes of the ghrelin ligand and receptor genes influence susceptibility to myocardial infarction and coronary artery disease.

Baessler A, Fischer M, Mayer B, Koehler M, Wiedmann S, Stark K, Doering A, Erdmann J, Riegger G, Schunkert H, Kwitek AE, Hengstenberg C.

Hum Mol Genet. 2007 Apr 15;16(8):887-99. Epub 2007 Feb 26.

PMID:
17324965
7.

Association of apolipoprotein E polymorphism with myocardial infarction in Greek patients with coronary artery disease.

Kolovou G, Yiannakouris N, Hatzivassiliou M, Malakos J, Daskalova D, Hatzigeorgiou G, Cariolou MA, Cokkinos DV.

Curr Med Res Opin. 2002;18(3):118-24.

PMID:
12094820
8.

Fibrinogen beta variants confer protection against coronary artery disease in a Greek case-control study.

Theodoraki EV, Nikopensius T, Suhorutsenko J, Peppes V, Fili P, Kolovou G, Papamikos V, Richter D, Zakopoulos N, Krjutskov K, Metspalu A, Dedoussis GV.

BMC Med Genet. 2010 Feb 18;11:28. doi: 10.1186/1471-2350-11-28.

9.

Soluble CD93 levels in patients with acute myocardial infarction and its implication on clinical outcome.

Youn JC, Yu HT, Jeon JW, Lee HS, Jang Y, Park YW, Park YB, Shin EC, Ha JW.

PLoS One. 2014 May 6;9(5):e96538. doi: 10.1371/journal.pone.0096538. eCollection 2014.

10.

The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.

Kadziela J, Janas J, Dzielińska Z, Szperl M, Gaździk D, Chotkowska E, Piotrowski W, Ruzyłło W.

Kardiol Pol. 2003 Jul;59(7):17-26; discussion 26.

PMID:
14560345
11.
12.

Homocysteine and risk of coronary artery disease: Folate is the important determinant of plasma homocysteine concentration.

Lee BJ, Lin PT, Liaw YP, Chang SJ, Cheng CH, Huang YC.

Nutrition. 2003 Jul-Aug;19(7-8):577-83.

PMID:
12831941
13.

Complement factor H Y402H polymorphism, plasma concentration and risk of coronary artery disease.

Qian Q, Chen Z, Ma G, Jiang Y, Feng Y, Shen C, Yao Y, Ding J, Dai Q, Li Y.

Mol Biol Rep. 2009 Jul;36(6):1257-61. doi: 10.1007/s11033-008-9306-4. Epub 2008 Jul 6.

PMID:
18604638
14.

The RANTES -403G>A promoter polymorphism in Korean men: association with serum RANTES concentration and coronary artery disease.

Jang Y, Chae JS, Hyun YJ, Koh SJ, Kim JY, Ko MJ, Rim SJ, Shin HJ, Ordovas JM, Lee JH.

Clin Sci (Lond). 2007 Oct;113(8):349-56.

PMID:
17504241
15.

Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction.

Topol EJ, McCarthy J, Gabriel S, Moliterno DJ, Rogers WJ, Newby LK, Freedman M, Metivier J, Cannata R, O'Donnell CJ, Kottke-Marchant K, Murugesan G, Plow EF, Stenina O, Daley GQ.

Circulation. 2001 Nov 27;104(22):2641-4.

16.

CD14 C(-260)-->T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease.

Koenig W, Khuseyinova N, Hoffmann MM, März W, Fröhlich M, Hoffmeister A, Brenner H, Rothenbacher D.

J Am Coll Cardiol. 2002 Jul 3;40(1):34-42.

17.

T-786C polymorphism in the endothelial nitric oxide synthase gene is associated with increased risk of coronary artery disease in a Chinese population.

Han Y, Xu W, Zhang W, Liu N, Ji Y.

Pharmacology. 2010;85(4):211-6. doi: 10.1159/000275135. Epub 2010 Mar 6.

PMID:
20215811
18.

Soluble Fas is a marker of coronary artery disease in patients with end-stage renal disease.

Hébert MJ, Masse M, Vigneault N, Sirois I, Troyanov S, Madore F.

Am J Kidney Dis. 2001 Dec;38(6):1271-6.

PMID:
11728960
19.

Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes.

Tsimikas S, Bergmark C, Beyer RW, Patel R, Pattison J, Miller E, Juliano J, Witztum JL.

J Am Coll Cardiol. 2003 Feb 5;41(3):360-70.

20.

Relationship between a novel polymorphism of hepatic lipase gene and coronary artery disease.

Su ZG, Zhang SZ, Hou YP, Zhang L, Huang DJ, Liao LC, Xiao CY.

Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2002 Nov;34(6):780-5.

Supplemental Content

Support Center